Polycomb group proteins and MYC: the cancer connection

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cellular and Molecular Life Sciences

• Publication date

  2013-07-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00018-013-1426-xPMID 23897499PMCID PMC11113285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Myc–microRNA network promotes exit from quiescence by suppressing the interferon response and cell-cycle arrest genes

  2013cited by this paper
• Non‐coding RNAs and EZH2 interactions in cancer: Long and short tales from the transcriptome

  2013cited by this paper
• Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation

  2013cited by this paper
• Epigenetic Regulation of Multiple Tumor-Related Genes Leads to Suppression of Breast Tumorigenesis by Dietary Genistein

  2013cited by this paper
• Polycomb-group proteins in hematopoietic stem cell regulation and hematopoietic neoplasms

  2013cited by this paper
• Cell Reprogramming Requires Silencing of a Core Subset of Polycomb Targets

  2013cited by this paper
• Ezh2 Orchestrates Topographic Migration and Connectivity of Mouse Precerebellar Neurons

  2013cited by this paper
• Human inactive X chromosome is compacted through a PRC2-independent SMCHD1-HBiX1 pathway

  2013cited by this paper
• Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma

  2013cited by this paper
• Noncoding RNA and Polycomb recruitment.

  2013cited by this paper
• From oncogene to tumor suppressor

  2012cited by this paper
• Dense Chromatin Activates Polycomb Repressive Complex 2 to Regulate H3 Lysine 27 Methylation

  2012cited by this paper
• Akt Phosphorylates the Transcriptional Repressor Bmi1 to Block Its Effects on the Tumor-Suppressing Ink4a-Arf Locus

  2012cited by this paper
• The functions of microRNAs in pluripotency and reprogramming

  2012cited by this paper
• Polycomb in stem cells: PRC1 branches out.

  2012cited by this paper
• Cross Talk Between MicroRNA and Coding Cancer Genes

  2012cited by this paper
• MAX and MYC: a heritable breakup.

  2012cited by this paper
• Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC

  2012cited by this paper
• Auto-regulation of miRNA biogenesis by let-7 and Argonaute

  2012cited by this paper
• EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

  2012cited by this paper
• EED mutants impair polycomb repressive complex 2 in myelodysplastic syndrome and related neoplasms

  2012cited by this paper
• Clinical outcome prediction by microRNAs in human cancer: a systematic review.

  2012cited by this paper
• Global levels of H3K27me3 track with differentiation in vivo and are deregulated by MYC in prostate cancer.

  2012cited by this paper
• Myc target miRs and liver cancer: small molecules to get Myc sick.

  2012cited by this paper
• Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity

  2012cited by this paper
• MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship

  2012cited by this paper
• A complex Polycomb issue: the two faces of EZH2 in cancer.

  2012cited by this paper
• Polycomb Group Protein PHF1 Regulates p53-dependent Cell Growth Arrest and Apoptosis*

  2012cited by this paper
• Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences

  2012cited by this paper
• A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.

  2012cited by this paper
• Polycomb Repressive Complex 1 (PRC1) Disassembles RNA Polymerase II Preinitiation Complexes*♦

  2012cited by this paper
• A Positive Feedback Loop Regulates the Expression of Polycomb Group Protein BMI1 via WNT Signaling Pathway*

  2012cited by this paper
• Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression.

  2012cited by this paper
• Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity

  2012cited by this paper
• EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

  2012cited by this paper
• Polycomb genes and cancer: time for clinical application?

  2012cited by this paper
• c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

  2012cited by this paper
• Abstract IA10: Spreading of X-chromosome inactivation via a hierarchy of defined Polycomb stations

  2012cited by this paper
• Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation

  2012cited by this paper
• A Polycomb Group Protein Is Retained at Specific Sites on Chromatin in Mitosis

  2012cited by this paper
• Human RNA methyltransferase BCDIN3D regulates microRNA processing.

  2012cited by this paper
• Transcriptional amplification in tumor cells with elevated c-Myc.

  2012cited by this paper
• The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis

  2012cited by this paper
• Polycomb repressive complex 2 is required for MLL-AF9 leukemia

  2012cited by this paper
• EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis

  2012cited by this paper
• Histone methylation: a dynamic mark in health, disease and inheritance

  2012cited by this paper
• Bmi1 overexpression in the cerebellar granule cell lineage of mice affects cell proliferation and survival without initiating medulloblastoma formation

  2012cited by this paper
• microRNAs in cancer management.

  2012cited by this paper
• Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.

  2012cited by this paper
• Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation

  2012cited by this paper
• Dysregulation of MicroRNAs in cancer

  2012cited by this paper
• Novel classes of non-coding RNAs and cancer

  2012cited by this paper
• A molecular roadmap of reprogramming somatic cells into iPS cells.

  2012cited by this paper
• Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas.

  2012cited by this paper
• Regulation of pluripotency and self- renewal of ESCs through epigenetic-threshold modulation and mRNA pruning.

  2012cited by this paper
• TrxG and PcG proteins but not methylated histones remain associated with DNA through replication.

  2012cited by this paper
• Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma.

  2012cited by this paper
• Regulation of gene transcription by the oncoprotein MYC.

  2012cited by this paper
• MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas

  2011cited by this paper
• Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms

  2011cited by this paper
• Myc Regulates the Transcription of the PRC2 Gene To Control the Expression of Developmental Genes in Embryonic Stem Cells

  2011cited by this paper
• The regulatory role of c-MYC on HDAC2 and PcG expression in human multipotent stem cells

  2011cited by this paper
• MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.

  2011cited by this paper
• Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells.

  2011cited by this paper
• The Myc/macrophage tango: oncogene-induced senescence, Myc style.

  2011cited by this paper
• BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer

  2011cited by this paper
• Tumor microenvironment: becoming sick of Myc

  2011cited by this paper
• BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

  2011cited by this paper
• Roles of the Polycomb group proteins in stem cells and cancer

  2011cited by this paper
• Amplification of the 20q Chromosomal Arm Occurs Early in Tumorigenic Transformation and May Initiate Cancer

  2011cited by this paper
• Histone methylation by PRC2 is inhibited by active chromatin marks.

  2011cited by this paper
• The Action Mechanism of the Myc Inhibitor Termed Omomyc May Give Clues on How to Target Myc for Cancer Therapy

  2011cited by this paper
• Finding cancer's weakest link

  2011cited by this paper
• Highly potent activity of (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in animal models of Parkinson's disease.

  2011cited by this paper
• MicroRNAs and epigenetics

  2011cited by this paper
• Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases—elevated Bmi-1 expression in late breast cancer relapses

  2011cited by this paper
• Polycomb group proteins: repression in 3D.

  2011cited by this paper
• Genetic Inactivation of the PRC2 Complex in T-Cell Acute Lymphoblastic Leukemia

  2011cited by this paper
• Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants.

  2011cited by this paper
• c-Myc induction of programmed cell death may contribute to carcinogenesis

  2011cited by this paper
• Evolution of microRNA diversity and regulation in animals

  2011cited by this paper
• Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features.

  2011cited by this paper
• Coordinated regulation of polycomb group complexes through microRNAs in cancer.

  2011cited by this paper
• Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2.

  2011cited by this paper
• The Polycomb complex PRC2 and its mark in life

  2011cited by this paper
• Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex

  2010cited by this paper
• A MicroRNA targeting dicer for metastasis control.

  2010cited by this paper
• Cdk2 suppresses cellular senescence induced by the c-myc oncogene

  2010cited by this paper
• MYC in oncogenesis and as a target for cancer therapies.

  2010cited by this paper
• Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway.

  2010cited by this paper
• Posttranscriptional regulation of microRNA biogenesis in animals.

  2010cited by this paper
• Roles of small RNAs in tumor formation.

  2010cited by this paper
• The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors

  2010cited by this paper
• Polycomb group proteins set the stage for early lineage commitment.

  2010cited by this paper
• Myc transcription factors: key regulators behind establishment and maintenance of pluripotency.

  2010cited by this paper
• Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue

  2010cited by this paper
• Polycomb proteins in hematologic malignancies.

  2010cited by this paper
• A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs.

  2010cited by this paper
• MYCN-regulated microRNAs repress estrogen receptor-α (ESR1) expression and neuronal differentiation in human neuroblastoma

  2010cited by this paper
• MicroRNA control of signal transduction

  2010cited by this paper

• Targeting the undruggable MYC in cancer: the rationale of using XPO1 inhibitors

  2025cites this paper
• Methylation Status at DMRs of C14MC and C19MC in Spermatozoa and Chorionic Villi of Individuals Experiencing Recurrent Spontaneous Abortions

  2024cites this paper
• Embryonic transcription and epigenetics: root of the evil

  2023cites this paper
• SUZ12 inhibition attenuates cell proliferation of glioblastoma via post-translational regulation of CDKN1B

  2023cites this paper
• MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma

  2023cites this paper
• IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2

  2022cites this paper
• Chromobox Homolog 8 (CBX8) in Human Tumor Carcinogenesis and Prognosis: A Pancancer Analysis Using Multiple Databases

  2021cites this paper
• Long noncoding RNAs (lncRNAs) in human lymphomas

  2021cites this paper
• No Easy Way Out for EZH2: Its Pleiotropic, Noncanonical Effects on Gene Regulation and Cellular Function

  2020cites this paper
• Enhancers and MYC interplay in hematopoiesis

  2020cites this paper
• Aggressive NK Cell Leukemia: Current State of the Art

  2020cites this paper
• Long non-coding RNAs and MYC association in hematological malignancies

  2020cites this paper
• Correlations between chromobox homolog 8 and key factors of epithelial–mesenchymal transition in hepatocellular carcinoma

  2019cites this paper
• Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo

  2019cites this paper
• Implication of integrin α2β1 in anoikis of SK-Mel-147 human melanoma cells: a non-canonical function of Akt protein kinase

  2019cites this paper
• Ubiquitin-specific protease 22 enhances intestinal cell proliferation and tissue regeneration after intestinal ischemia reperfusion injury

  2019cites this paper
• CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma

  2019cites this paper
• Downregulated Expression of Chromobox Homolog 7 in Hepatocellular Carcinoma

  2019cites this paper
• MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma.

  2018cites this paper
• EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes.

  2018cites this paper
• Implication of Integrin α2β1 in Proliferation and Invasion of Human Breast Carcinoma and Melanoma Cells: Noncanonical Function of Akt Protein Kinase

  2018cites this paper
• High MYC Levels Favour Multifocal Carcinogenesis

  2018cites this paper
• Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2

  2017cites this paper
• EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution

  2017cites this paper
• Transcriptome analyses of rhesus monkey preimplantation embryos reveal a reduced capacity for DNA double-strand break repair in primate oocytes and early embryos.

  2017cites this paper
• VALIDATION OF ASSESSMENT OF BMI-1 ON PROTEIN AND MOLECULAR LEVELS IN ORAL DYSPLASIA AND SQUAMOUS CELL CARCINOMA. (A DIAGNOSTIC STUDY)

  2017influential citation
• Epigenetic and genetic changes in soft tissue sarcomas: a review

  2016cites this paper
• CD99 Is Strongly Expressed in Basal Cells of the Normal Adult Epidermis and Some Subpopulations of Appendages: Comparison with Developing Fetal Skin

  2016cites this paper
• Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies

  2016cites this paper
• The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications

  2016cites this paper
• An Efficient Branch and Cut Algorithm to Find Frequently Mutated Subnetworks in Cancer

  2016cites this paper
• Long Non-coding RNA HOTAIR Expression in Diffuse Large B-Cell Lymphoma: In Relation to Polycomb Repressive Complex Pathway Proteins and H3K27 Trimethylation

  2016cites this paper
• MicroRNA involvement in breast cancer susceptibility and progression

  2016cites this paper
• MycN Is Critical for the Maintenance of Human Embryonic Stem Cell-Derived Neural Crest Stem Cells

  2016cites this paper
• Combined Overexpression of JARID2, PRDM14, ESRRB, and SALL4A Dramatically Improves Efficiency and Kinetics of Reprogramming to Induced Pluripotent Stem Cells

  2016cites this paper
• Activation of the polycomb repressive complex pathway in the bone marrow resident cells of diffuse large B-cell lymphoma patients

  2016cites this paper
• Interplay of H2A deubiquitinase 2A-DUB/Mysm1 and the p19ARF/p53 axis in hematopoiesis, early T-cell development and tissue differentiation

  2015cites this paper
• BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.

  2015cites this paper
• Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis

  2015cites this paper
• MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer

  2015cites this paper
• A Novel Aspect of Tumorigenesis—BMI1 Functions in Regulating DNA Damage Response

  2015cites this paper
• YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis

  2015cites this paper
• Rapamycin, a mTOR inhibitor, induced growth inhibition in retinoblastoma Y79 cell via down-regulation of Bmi-1.

  2015cites this paper
• Radiation therapy for glioma stem cells.

  2015cites this paper
• Implication of α2β1 integrin in anoikis of MCF-7 human breast carcinoma cells

  2015cites this paper
• T-cell Prolymphocytic Leukemia Frequently Shows Cutaneous Involvement and Is Associated With Gains of MYC, Loss of ATM, and TCL1A Rearrangement

  2014cites this paper
• O-GlcNAcylation and Metabolic Reprograming in Cancer

  2014cites this paper
• MicroRNA-33b Suppresses Migration and Invasion by Targeting c-Myc in Osteosarcoma Cells

  2014cites this paper
• MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer

  2014cites this paper
• Identification of gene expression profiles differentially expressed in myxoid and round cell liposarcomas

  2014cites this paper
• Identification of a gene expression driven progression pathway in myxoid liposarcoma

  2014cites this paper
• Neonatal tumours

  2013cites this paper